BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37259865)

  • 1. CD47 Activation by Thrombospondin-1 in Lymphatic Endothelial Cells Suppresses Lymphangiogenesis and Promotes Atherosclerosis.
    Singla B; Aithbathula RV; Pervaiz N; Kathuria I; Swanson M; Ekuban FA; Ahn W; Park F; Gyamfi M; Cherian-Shaw M; Singh UP; Kumar S
    Arterioscler Thromb Vasc Biol; 2023 Jul; 43(7):1234-1250. PubMed ID: 37259865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of R-spondin 2 in arterial lymphangiogenesis and atherosclerosis.
    Singla B; Lin HP; Chen A; Ahn W; Ghoshal P; Cherian-Shaw M; White J; Stansfield BK; Csányi G
    Cardiovasc Res; 2021 May; 117(6):1489-1509. PubMed ID: 32750106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction.
    Rogers NM; Sharifi-Sanjani M; Yao M; Ghimire K; Bienes-Martinez R; Mutchler SM; Knupp HE; Baust J; Novelli EM; Ross M; St Croix C; Kutten JC; Czajka CA; Sembrat JC; Rojas M; Labrousse-Arias D; Bachman TN; Vanderpool RR; Zuckerbraun BS; Champion HC; Mora AL; Straub AC; Bilonick RA; Calzada MJ; Isenberg JS
    Cardiovasc Res; 2017 Jan; 113(1):15-29. PubMed ID: 27742621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.
    Kaur S; Martin-Manso G; Pendrak ML; Garfield SH; Isenberg JS; Roberts DD
    J Biol Chem; 2010 Dec; 285(50):38923-32. PubMed ID: 20923780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidatively Modified LDL Suppresses Lymphangiogenesis via CD36 Signaling.
    Singla B; Lin HP; Ahn W; White J; Csányi G
    Antioxidants (Basel); 2021 Feb; 10(2):. PubMed ID: 33672291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular TSP1-CD47 signaling promotes sickle cell-associated arterial vasculopathy and pulmonary hypertension in mice.
    Novelli EM; Little-Ihrig L; Knupp HE; Rogers NM; Yao M; Baust JJ; Meijles D; St Croix CM; Ross MA; Pagano PJ; DeVallance ER; Miles G; Potoka KP; Isenberg JS; Gladwin MT
    Am J Physiol Lung Cell Mol Physiol; 2019 Jun; 316(6):L1150-L1164. PubMed ID: 30892078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombospondin-1 signaling through CD47 inhibits cell cycle progression and induces senescence in endothelial cells.
    Gao Q; Chen K; Gao L; Zheng Y; Yang YG
    Cell Death Dis; 2016 Sep; 7(9):e2368. PubMed ID: 27607583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation.
    Bauer EM; Qin Y; Miller TW; Bandle RW; Csanyi G; Pagano PJ; Bauer PM; Schnermann J; Roberts DD; Isenberg JS
    Cardiovasc Res; 2010 Dec; 88(3):471-81. PubMed ID: 20610415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The matricellular protein TSP1 promotes human and mouse endothelial cell senescence through CD47 and Nox1.
    Meijles DN; Sahoo S; Al Ghouleh I; Amaral JH; Bienes-Martinez R; Knupp HE; Attaran S; Sembrat JC; Nouraie SM; Rojas MM; Novelli EM; Gladwin MT; Isenberg JS; Cifuentes-Pagano E; Pagano PJ
    Sci Signal; 2017 Oct; 10(501):. PubMed ID: 29042481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD47 signaling regulates the immunosuppressive activity of VEGF in T cells.
    Kaur S; Chang T; Singh SP; Lim L; Mannan P; Garfield SH; Pendrak ML; Soto-Pantoja DR; Rosenberg AZ; Jin S; Roberts DD
    J Immunol; 2014 Oct; 193(8):3914-24. PubMed ID: 25200950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts.
    Isenberg JS; Pappan LK; Romeo MJ; Abu-Asab M; Tsokos M; Wink DA; Frazier WA; Roberts DD
    Ann Surg; 2008 Jan; 247(1):180-90. PubMed ID: 18156939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1.
    Bauer PM; Bauer EM; Rogers NM; Yao M; Feijoo-Cuaresma M; Pilewski JM; Champion HC; Zuckerbraun BS; Calzada MJ; Isenberg JS
    Cardiovasc Res; 2012 Mar; 93(4):682-93. PubMed ID: 22215724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombospondin 1 in Metabolic Diseases.
    Gutierrez LS; Gutierrez J
    Front Endocrinol (Lausanne); 2021; 12():638536. PubMed ID: 33854480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake.
    Isenberg JS; Jia Y; Fukuyama J; Switzer CH; Wink DA; Roberts DD
    J Biol Chem; 2007 May; 282(21):15404-15. PubMed ID: 17416590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC6 Suppresses Let-7i-5p to Elicit TSP1/CD47-Mediated Anti-Tumorigenesis and Phagocytosis of Hepatocellular Carcinoma.
    Yang HD; Kim HS; Kim SY; Na MJ; Yang G; Eun JW; Wang HJ; Cheong JY; Park WS; Nam SW
    Hepatology; 2019 Oct; 70(4):1262-1279. PubMed ID: 30991448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking thrombospondin-1 signaling via CD47 mitigates renal interstitial fibrosis.
    Julovi SM; Sanganeria B; Minhas N; Ghimire K; Nankivell B; Rogers NM
    Lab Invest; 2020 Sep; 100(9):1184-1196. PubMed ID: 32366943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TSP1 ameliorates age-related macular degeneration by regulating the STAT3-iNOS signaling pathway.
    Li J; He J; Zhang X; Li J; Zhao P; Fei P
    Exp Cell Res; 2020 Mar; 388(1):111811. PubMed ID: 31899207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of cross-talk between the cell-surface proteins CD36 and CD47-TSP-1 in osteoclast formation and function.
    Koduru SV; Sun BH; Walker JM; Zhu M; Simpson C; Dhodapkar M; Insogna KL
    J Biol Chem; 2018 Sep; 293(39):15055-15069. PubMed ID: 30082316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation.
    Isenberg JS; Shiva S; Gladwin M
    Nitric Oxide; 2009 Aug; 21(1):52-62. PubMed ID: 19481167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking thrombospondin-1/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia.
    Isenberg JS; Hyodo F; Pappan LK; Abu-Asab M; Tsokos M; Krishna MC; Frazier WA; Roberts DD
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2582-8. PubMed ID: 17916772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.